Cigna earnings beat by $0.04, revenue topped estimates
Investing.com -- Kewaunee Scientific Corporation (NASDAQ:KEQU) reported fourth quarter earnings that significantly exceeded previous results, driving shares up 23.5% in after-hours trading.
The laboratory furniture and equipment maker posted adjusted earnings per share of $1.95 for the quarter ended April 30, 2025, while revenue jumped 36.1% YoY to $77.15 million.
Kewaunee’s strong performance was driven by a 54.7% increase in domestic sales to $55.49 million. International sales rose 3.9% to $21.66 million.
"Kewaunee again delivered another strong quarter, closing out fiscal year 2025 on a high note," said Thomas D. Hull III, President and CEO. "Our team continues to embrace the momentum we have generated in the market, delivering on our commitments to our customers."
The company’s order backlog stood at $214.6 million as of April 30, 2025, up from $155.6 million a year earlier.
For the full fiscal year 2025, Kewaunee reported adjusted earnings per share of $5.37 on revenue of $240.47 million, representing increases of 28.2% and 18% respectively from the prior year.
Looking ahead, Hull expressed optimism about Kewaunee’s growth prospects, both organic and through acquisitions, following its recent purchase of Nu Aire, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.